APO Research
Talk to an analyst

APO RESEARCH · REPORT

Regorafenib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Regorafenib Market Analysis and Forecast 2026-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchRegorafenib Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Regorafenib Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Regorafenib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Regorafenib Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Regorafenib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Regorafenib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Regorafenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Regorafenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Regorafenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Regorafenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Regorafenib include Beacon Pharmaceuticals, Bayer Pharmaceuticals and Drug International, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Regorafenib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Regorafenib, also provides the sales of main regions and countries. Of the upcoming market potential for Regorafenib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Regorafenib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Regorafenib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Regorafenib sales, projected growth trends, production technology, application and end-user industry.

Regorafenib Segment by Company

Beacon Pharmaceuticals

Bayer Pharmaceuticals

Drug International

Regorafenib Segment by Type

Bottled Packaging

Film Coated Packaging

Regorafenib Segment by Application

Advanced Hepatocellular Carcinoma

Advanced Gastrointestinal Stromal Tumours

Metastatic Colorectal Cancer

Others

Regorafenib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Regorafenib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Regorafenib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Regorafenib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Regorafenib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Regorafenib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Regorafenib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Regorafenib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bottled Packaging Major Manufacturers Table 3. Film Coated Packaging Major Manufacturers Table 4. Global Regorafenib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Advanced Hepatocellular Carcinoma Major Manufacturers Table 6. Advanced Gastrointestinal Stromal Tumours Major Manufacturers Table 7. Metastatic Colorectal Cancer Major Manufacturers Table 8. Others Major Manufacturers Table 9. Regorafenib Industry Trends Table 10. Regorafenib Industry Drivers Table 11. Regorafenib Industry Opportunities and Challenges Table 12. Regorafenib Industry Restraints Table 13. Global Regorafenib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Regorafenib Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Regorafenib Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Regorafenib Revenue Market Share by Region (2021-2026) Table 17. Global Regorafenib Revenue Market Share by Region (2027-2032) Table 18. Global Regorafenib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 19. Global Regorafenib Sales by Region (2021-2026) & (k pcs) Table 20. Global Regorafenib Sales by Region (2027-2032) & (k pcs) Table 21. Global Regorafenib Sales Market Share by Region (2021-2026) Table 22. Global Regorafenib Sales Market Share by Region (2027-2032) Table 23. Global Regorafenib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Regorafenib Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Regorafenib Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Regorafenib Sales Market Share by Manufacturers (2021-2026) Table 27. Global Regorafenib Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 28. Global Regorafenib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Regorafenib Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Regorafenib Manufacturers, Product Type & Application Table 31. Global Regorafenib Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Regorafenib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Regorafenib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Regorafenib Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Regorafenib Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Regorafenib Revenue Market Share by Type (2021-2026) Table 38. Global Regorafenib Revenue Market Share by Type (2027-2032) Table 39. Global Regorafenib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 40. Global Regorafenib Sales by Type (2021-2026) & (k pcs) Table 41. Global Regorafenib Sales by Type (2027-2032) & (k pcs) Table 42. Global Regorafenib Sales Market Share by Type (2021-2026) Table 43. Global Regorafenib Sales Market Share by Type (2027-2032) Table 44. Global Regorafenib Price by Type (2021-2026) & (US$/pcs) Table 45. Global Regorafenib Price by Type (2027-2032) & (US$/pcs) Table 46. Global Regorafenib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Regorafenib Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Regorafenib Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Regorafenib Revenue Market Share by Application (2021-2026) Table 50. Global Regorafenib Revenue Market Share by Application (2027-2032) Table 51. Global Regorafenib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 52. Global Regorafenib Sales by Application (2021-2026) & (k pcs) Table 53. Global Regorafenib Sales by Application (2027-2032) & (k pcs) Table 54. Global Regorafenib Sales Market Share by Application (2021-2026) Table 55. Global Regorafenib Sales Market Share by Application (2027-2032) Table 56. Global Regorafenib Price by Application (2021-2026) & (US$/pcs) Table 57. Global Regorafenib Price by Application (2027-2032) & (US$/pcs) Table 58. Beacon Pharmaceuticals Company Information Table 59. Beacon Pharmaceuticals Business Overview Table 60. Beacon Pharmaceuticals Regorafenib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 61. Beacon Pharmaceuticals Regorafenib Product Portfolio Table 62. Beacon Pharmaceuticals Recent Development Table 63. Bayer Pharmaceuticals Company Information Table 64. Bayer Pharmaceuticals Business Overview Table 65. Bayer Pharmaceuticals Regorafenib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 66. Bayer Pharmaceuticals Regorafenib Product Portfolio Table 67. Bayer Pharmaceuticals Recent Development Table 68. Drug International Company Information Table 69. Drug International Business Overview Table 70. Drug International Regorafenib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 71. Drug International Regorafenib Product Portfolio Table 72. Drug International Recent Development Table 73. North America Regorafenib Revenue by Type (2021-2026) & (US$ Million) Table 74. North America Regorafenib Revenue by Type (2027-2032) & (US$ Million) Table 75. North America Regorafenib Sales by Type (2021-2026) & (k pcs) Table 76. North America Regorafenib Sales by Type (2027-2032) & (k pcs) Table 77. North America Regorafenib Sales Price by Type (2021-2026) & (US$/pcs) Table 78. North America Regorafenib Sales Price by Type (2027-2032) & (US$/pcs) Table 79. North America Regorafenib Revenue by Application (2021-2026) & (US$ Million) Table 80. North America Regorafenib Revenue by Application (2027-2032) & (US$ Million) Table 81. North America Regorafenib Sales by Application (2021-2026) & (k pcs) Table 82. North America Regorafenib Sales by Application (2027-2032) & (k pcs) Table 83. North America Regorafenib Sales Price by Application (2021-2026) & (US$/pcs) Table 84. North America Regorafenib Sales Price by Application (2027-2032) & (US$/pcs) Table 85. North America Regorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Regorafenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 87. North America Regorafenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 88. North America Regorafenib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 89. North America Regorafenib Sales by Country (2021-2026) & (k pcs) Table 90. North America Regorafenib Sales by Country (2027-2032) & (k pcs) Table 91. North America Regorafenib Sales Price by Country (2021-2026) & (US$/pcs) Table 92. North America Regorafenib Sales Price by Country (2027-2032) & (US$/pcs) Table 93. United States Regorafenib Revenue (2021-2032) & (US$ Million) Table 94. Canada Regorafenib Revenue (2021-2032) & (US$ Million) Table 95. Mexico Regorafenib Revenue (2021-2032) & (US$ Million) Table 96. Europe Regorafenib Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Regorafenib Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Regorafenib Sales by Type (2021-2026) & (k pcs) Table 99. Europe Regorafenib Sales by Type (2027-2032) & (k pcs) Table 100. Europe Regorafenib Sales Price by Type (2021-2026) & (US$/pcs) Table 101. Europe Regorafenib Sales Price by Type (2027-2032) & (US$/pcs) Table 102. Europe Regorafenib Revenue by Application (2021-2026) & (US$ Million) Table 103. Europe Regorafenib Revenue by Application (2027-2032) & (US$ Million) Table 104. Europe Regorafenib Sales by Application (2021-2026) & (k pcs) Table 105. Europe Regorafenib Sales by Application (2027-2032) & (k pcs) Table 106. Europe Regorafenib Sales Price by Application (2021-2026) & (US$/pcs) Table 107. Europe Regorafenib Sales Price by Application (2027-2032) & (US$/pcs) Table 108. Europe Regorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Regorafenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. Europe Regorafenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. Europe Regorafenib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 112. Europe Regorafenib Sales by Country (2021-2026) & (k pcs) Table 113. Europe Regorafenib Sales by Country (2027-2032) & (k pcs) Table 114. Europe Regorafenib Sales Price by Country (2021-2026) & (US$/pcs) Table 115. Europe Regorafenib Sales Price by Country (2027-2032) & (US$/pcs) Table 116. Germany Regorafenib Revenue (2021-2032) & (US$ Million) Table 117. France Regorafenib Revenue (2021-2032) & (US$ Million) Table 118. U.K. Regorafenib Revenue (2021-2032) & (US$ Million) Table 119. Italy Regorafenib Revenue (2021-2032) & (US$ Million) Table 120. Russia Regorafenib Revenue (2021-2032) & (US$ Million) Table 121. Spain Regorafenib Revenue (2021-2032) & (US$ Million) Table 122. Netherlands Regorafenib Revenue (2021-2032) & (US$ Million) Table 123. Switzerland Regorafenib Revenue (2021-2032) & (US$ Million) Table 124. Sweden Regorafenib Revenue (2021-2032) & (US$ Million) Table 125. Poland Regorafenib Revenue (2021-2032) & (US$ Million) Table 126. China Regorafenib Revenue by Type (2021-2026) & (US$ Million) Table 127. China Regorafenib Revenue by Type (2027-2032) & (US$ Million) Table 128. China Regorafenib Sales by Type (2021-2026) & (k pcs) Table 129. China Regorafenib Sales by Type (2027-2032) & (k pcs) Table 130. China Regorafenib Sales Price by Type (2021-2026) & (US$/pcs) Table 131. China Regorafenib Sales Price by Type (2027-2032) & (US$/pcs) Table 132. China Regorafenib Revenue by Application (2021-2026) & (US$ Million) Table 133. China Regorafenib Revenue by Application (2027-2032) & (US$ Million) Table 134. China Regorafenib Sales by Application (2021-2026) & (k pcs) Table 135. China Regorafenib Sales by Application (2027-2032) & (k pcs) Table 136. China Regorafenib Sales Price by Application (2021-2026) & (US$/pcs) Table 137. China Regorafenib Sales Price by Application (2027-2032) & (US$/pcs) Table 138. Asia Regorafenib Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Regorafenib Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Regorafenib Sales by Type (2021-2026) & (k pcs) Table 141. Asia Regorafenib Sales by Type (2027-2032) & (k pcs) Table 142. Asia Regorafenib Sales Price by Type (2021-2026) & (US$/pcs) Table 143. Asia Regorafenib Sales Price by Type (2027-2032) & (US$/pcs) Table 144. Asia Regorafenib Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Regorafenib Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Regorafenib Sales by Application (2021-2026) & (k pcs) Table 147. Asia Regorafenib Sales by Application (2027-2032) & (k pcs) Table 148. Asia Regorafenib Sales Price by Application (2021-2026) & (US$/pcs) Table 149. Asia Regorafenib Sales Price by Application (2027-2032) & (US$/pcs) Table 150. Asia Regorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia Regorafenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Asia Regorafenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Asia Regorafenib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 154. Asia Regorafenib Sales by Country (2021-2026) & (k pcs) Table 155. Asia Regorafenib Sales by Country (2027-2032) & (k pcs) Table 156. Asia Regorafenib Sales Price by Country (2021-2026) & (US$/pcs) Table 157. Asia Regorafenib Sales Price by Country (2027-2032) & (US$/pcs) Table 158. Japan Regorafenib Revenue (2021-2032) & (US$ Million) Table 159. South Korea Regorafenib Revenue (2021-2032) & (US$ Million) Table 160. India Regorafenib Revenue (2021-2032) & (US$ Million) Table 161. Australia Regorafenib Revenue (2021-2032) & (US$ Million) Table 162. Taiwan Regorafenib Revenue (2021-2032) & (US$ Million) Table 163. Southeast Asia Regorafenib Revenue (2021-2032) & (US$ Million) Table 164. SAMEA Regorafenib Revenue by Type (2021-2026) & (US$ Million) Table 165. SAMEA Regorafenib Revenue by Type (2027-2032) & (US$ Million) Table 166. SAMEA Regorafenib Sales by Type (2021-2026) & (k pcs) Table 167. SAMEA Regorafenib Sales by Type (2027-2032) & (k pcs) Table 168. SAMEA Regorafenib Sales Price by Type (2021-2026) & (US$/pcs) Table 169. SAMEA Regorafenib Sales Price by Type (2027-2032) & (US$/pcs) Table 170. SAMEA Regorafenib Revenue by Application (2021-2026) & (US$ Million) Table 171. SAMEA Regorafenib Revenue by Application (2027-2032) & (US$ Million) Table 172. SAMEA Regorafenib Sales by Application (2021-2026) & (k pcs) Table 173. SAMEA Regorafenib Sales by Application (2027-2032) & (k pcs) Table 174. SAMEA Regorafenib Sales Price by Application (2021-2026) & (US$/pcs) Table 175. SAMEA Regorafenib Sales Price by Application (2027-2032) & (US$/pcs) Table 176. SAMEA Regorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. SAMEA Regorafenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. SAMEA Regorafenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. SAMEA Regorafenib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 180. SAMEA Regorafenib Sales by Country (2021-2026) & (k pcs) Table 181. SAMEA Regorafenib Sales by Country (2027-2032) & (k pcs) Table 182. SAMEA Regorafenib Sales Price by Country (2021-2026) & (US$/pcs) Table 183. SAMEA Regorafenib Sales Price by Country (2027-2032) & (US$/pcs) Table 184. Brazil Regorafenib Revenue (2021-2032) & (US$ Million) Table 185. Argentina Regorafenib Revenue (2021-2032) & (US$ Million) Table 186. Chile Regorafenib Revenue (2021-2032) & (US$ Million) Table 187. Colombia Regorafenib Revenue (2021-2032) & (US$ Million) Table 188. Peru Regorafenib Revenue (2021-2032) & (US$ Million) Table 189. Saudi Arabia Regorafenib Revenue (2021-2032) & (US$ Million) Table 190. Israel Regorafenib Revenue (2021-2032) & (US$ Million) Table 191. UAE Regorafenib Revenue (2021-2032) & (US$ Million) Table 192. Turkey Regorafenib Revenue (2021-2032) & (US$ Million) Table 193. Iran Regorafenib Revenue (2021-2032) & (US$ Million) Table 194. Egypt Regorafenib Revenue (2021-2032) & (US$ Million) Table 195. Key Raw Materials Table 196. Raw Materials Key Suppliers Table 197. Regorafenib Distributors List Table 198. Regorafenib Customers List Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Regorafenib Image Figure 2. Global Regorafenib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Regorafenib Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bottled Packaging Image Figure 5. Film Coated Packaging Image Figure 6. Global Regorafenib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Regorafenib Market Size Share 2021 VS 2025 VS 2032 Figure 8. Advanced Hepatocellular Carcinoma Image Figure 9. Advanced Gastrointestinal Stromal Tumours Image Figure 10. Metastatic Colorectal Cancer Image Figure 11. Others Image Figure 12. Global Regorafenib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Regorafenib Revenue (2021-2032) & (US$ Million) Figure 14. Global Regorafenib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Regorafenib Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Regorafenib Revenue Market Share by Region (2021-2032) Figure 17. Global Regorafenib Sales (2021-2032) & (k pcs) Figure 18. Global Regorafenib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 19. Global Regorafenib Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Regorafenib Sales YoY (2021-2032) & (k pcs) Figure 21. Europe Regorafenib Sales YoY (2021-2032) & (k pcs) Figure 22. China Regorafenib Sales YoY (2021-2032) & (k pcs) Figure 23. Asia (Excluding China) Regorafenib Sales YoY (2021-2032) & (k pcs) Figure 24. South America, Middle East and Africa Regorafenib Sales YoY (2021-2032) & (k pcs) Figure 25. Global Regorafenib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Regorafenib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Regorafenib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Regorafenib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Regorafenib Revenue Market Share by Type (2021-2032) Figure 31. Global Regorafenib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 32. Global Regorafenib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Regorafenib Sales Market Share by Type (2021-2032) Figure 34. Global Regorafenib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Regorafenib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Regorafenib Revenue Market Share by Application (2021-2032) Figure 37. Global Regorafenib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 38. Global Regorafenib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Regorafenib Sales Market Share by Application (2021-2032) Figure 40. North America Regorafenib Revenue Share by Type (2021-2032) Figure 41. North America Regorafenib Sales Share by Type (2021-2032) Figure 42. North America Regorafenib Revenue Share by Application (2021-2032) Figure 43. North America Regorafenib Sales Share by Application (2021-2032) Figure 44. North America Regorafenib Revenue Share by Country (2021-2032) Figure 45. North America Regorafenib Sales Share by Country (2021-2032) Figure 46. Europe Regorafenib Revenue Share by Type (2021-2032) Figure 47. Europe Regorafenib Sales Share by Type (2021-2032) Figure 48. Europe Regorafenib Revenue Share by Application (2021-2032) Figure 49. Europe Regorafenib Sales Share by Application (2021-2032) Figure 50. Europe Regorafenib Revenue Share by Country (2021-2032) Figure 51. Europe Regorafenib Sales Share by Country (2021-2032) Figure 52. China Regorafenib Revenue Share by Type (2021-2032) Figure 53. China Regorafenib Sales Share by Type (2021-2032) Figure 54. China Regorafenib Revenue Share by Application (2021-2032) Figure 55. China Regorafenib Sales Share by Application (2021-2032) Figure 56. Asia Regorafenib Revenue Share by Type (2021-2032) Figure 57. Asia Regorafenib Sales Share by Type (2021-2032) Figure 58. Asia Regorafenib Revenue Share by Application (2021-2032) Figure 59. Asia Regorafenib Sales Share by Application (2021-2032) Figure 60. Asia Regorafenib Revenue Share by Country (2021-2032) Figure 61. Asia Regorafenib Sales Share by Country (2021-2032) Figure 62. SAMEA Regorafenib Revenue Share by Type (2021-2032) Figure 63. SAMEA Regorafenib Sales Share by Type (2021-2032) Figure 64. SAMEA Regorafenib Revenue Share by Application (2021-2032) Figure 65. SAMEA Regorafenib Sales Share by Application (2021-2032) Figure 66. SAMEA Regorafenib Revenue Share by Country (2021-2032) Figure 67. SAMEA Regorafenib Sales Share by Country (2021-2032) Figure 68. Regorafenib Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Regorafenib Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Bottled Packaging
  • Film Coated Packaging
Applications
  • Advanced Hepatocellular Carcinoma
  • Advanced Gastrointestinal Stromal Tumours
  • Metastatic Colorectal Cancer
  • Others
Companies covered
  • Beacon Pharmaceuticals
  • Bayer Pharmaceuticals
  • Drug International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Regorafenib Market by Type
  3. 1.2.1 Global Regorafenib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bottled Packaging
  5. 1.2.3 Film Coated Packaging
  6. 1.3 Regorafenib Market by Application
  7. 1.3.1 Global Regorafenib Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Advanced Hepatocellular Carcinoma
  9. 1.3.3 Advanced Gastrointestinal Stromal Tumours
  10. 1.3.4 Metastatic Colorectal Cancer
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Regorafenib Market Dynamics
  1. 2.1 Regorafenib Industry Trends
  2. 2.2 Regorafenib Industry Drivers
  3. 2.3 Regorafenib Industry Opportunities and Challenges
  4. 2.4 Regorafenib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Regorafenib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Regorafenib Revenue by Region
  3. 3.2.1 Global Regorafenib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Regorafenib Revenue by Region (2021-2026)
  5. 3.2.3 Global Regorafenib Revenue by Region (2027-2032)
  6. 3.2.4 Global Regorafenib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Regorafenib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Regorafenib Sales by Region
  9. 3.4.1 Global Regorafenib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Regorafenib Sales by Region (2021-2026)
  11. 3.4.3 Global Regorafenib Sales by Region (2027-2032)
  12. 3.4.4 Global Regorafenib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Regorafenib Revenue by Manufacturers
  2. 4.1.1 Global Regorafenib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Regorafenib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Regorafenib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Regorafenib Sales by Manufacturers
  6. 4.2.1 Global Regorafenib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Regorafenib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Regorafenib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Regorafenib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Regorafenib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Regorafenib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Regorafenib Manufacturers, Product Type & Application
  13. 4.7 Global Regorafenib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Regorafenib Market CR5 and HHI
  16. 4.8.2 2025 Regorafenib Tier 1, Tier 2, and Tier 3
5 Regorafenib Market by Type
  1. 5.1 Global Regorafenib Revenue by Type
  2. 5.1.1 Global Regorafenib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Regorafenib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Regorafenib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Regorafenib Sales by Type
  6. 5.2.1 Global Regorafenib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Regorafenib Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Regorafenib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Regorafenib Price by Type
6 Regorafenib Market by Application
  1. 6.1 Global Regorafenib Revenue by Application
  2. 6.1.1 Global Regorafenib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Regorafenib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Regorafenib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Regorafenib Sales by Application
  6. 6.2.1 Global Regorafenib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Regorafenib Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Regorafenib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Regorafenib Price by Application
7 Company Profiles
  1. 7.1 Beacon Pharmaceuticals
  2. 7.1.1 Beacon Pharmaceuticals Company Information
  3. 7.1.2 Beacon Pharmaceuticals Business Overview
  4. 7.1.3 Beacon Pharmaceuticals Regorafenib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Beacon Pharmaceuticals Regorafenib Product Portfolio
  6. 7.1.5 Beacon Pharmaceuticals Recent Developments
  7. 7.2 Bayer Pharmaceuticals
  8. 7.2.1 Bayer Pharmaceuticals Company Information
  9. 7.2.2 Bayer Pharmaceuticals Business Overview
  10. 7.2.3 Bayer Pharmaceuticals Regorafenib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Pharmaceuticals Regorafenib Product Portfolio
  12. 7.2.5 Bayer Pharmaceuticals Recent Developments
  13. 7.3 Drug International
  14. 7.3.1 Drug International Company Information
  15. 7.3.2 Drug International Business Overview
  16. 7.3.3 Drug International Regorafenib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Drug International Regorafenib Product Portfolio
  18. 7.3.5 Drug International Recent Developments
8 North America
  1. 8.1 North America Regorafenib Market Size by Type
  2. 8.1.1 North America Regorafenib Revenue by Type (2021-2032)
  3. 8.1.2 North America Regorafenib Sales by Type (2021-2032)
  4. 8.1.3 North America Regorafenib Price by Type (2021-2032)
  5. 8.2 North America Regorafenib Market Size by Application
  6. 8.2.1 North America Regorafenib Revenue by Application (2021-2032)
  7. 8.2.2 North America Regorafenib Sales by Application (2021-2032)
  8. 8.2.3 North America Regorafenib Price by Application (2021-2032)
  9. 8.3 North America Regorafenib Market Size by Country
  10. 8.3.1 North America Regorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Regorafenib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Regorafenib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Regorafenib Market Size by Type
  2. 9.1.1 Europe Regorafenib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Regorafenib Sales by Type (2021-2032)
  4. 9.1.3 Europe Regorafenib Price by Type (2021-2032)
  5. 9.2 Europe Regorafenib Market Size by Application
  6. 9.2.1 Europe Regorafenib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Regorafenib Sales by Application (2021-2032)
  8. 9.2.3 Europe Regorafenib Price by Application (2021-2032)
  9. 9.3 Europe Regorafenib Market Size by Country
  10. 9.3.1 Europe Regorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Regorafenib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Regorafenib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Regorafenib Market Size by Type
  2. 10.1.1 China Regorafenib Revenue by Type (2021-2032)
  3. 10.1.2 China Regorafenib Sales by Type (2021-2032)
  4. 10.1.3 China Regorafenib Price by Type (2021-2032)
  5. 10.2 China Regorafenib Market Size by Application
  6. 10.2.1 China Regorafenib Revenue by Application (2021-2032)
  7. 10.2.2 China Regorafenib Sales by Application (2021-2032)
  8. 10.2.3 China Regorafenib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Regorafenib Market Size by Type
  2. 11.1.1 Asia Regorafenib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Regorafenib Sales by Type (2021-2032)
  4. 11.1.3 Asia Regorafenib Price by Type (2021-2032)
  5. 11.2 Asia Regorafenib Market Size by Application
  6. 11.2.1 Asia Regorafenib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Regorafenib Sales by Application (2021-2032)
  8. 11.2.3 Asia Regorafenib Price by Application (2021-2032)
  9. 11.3 Asia Regorafenib Market Size by Country
  10. 11.3.1 Asia Regorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Regorafenib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Regorafenib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Regorafenib Market Size by Type
  2. 12.1.1 SAMEA Regorafenib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Regorafenib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Regorafenib Price by Type (2021-2032)
  5. 12.2 SAMEA Regorafenib Market Size by Application
  6. 12.2.1 SAMEA Regorafenib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Regorafenib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Regorafenib Price by Application (2021-2032)
  9. 12.3 SAMEA Regorafenib Market Size by Country
  10. 12.3.1 SAMEA Regorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Regorafenib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Regorafenib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Regorafenib Value Chain Analysis
  2. 13.1.1 Regorafenib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Regorafenib Production Mode & Process
  6. 13.2 Regorafenib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Regorafenib Distributors
  9. 13.2.3 Regorafenib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst